Approved Enterprise Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Approved Enterprise Formulary
Search results for:

pancrelipase

pancrelipase
Drug Name Form Strength Ambulatory Use Only Ambulatory Restrictions Inpatient Restrictions Non-Formulary
Creon DELAYED RELEASE CAPSULE, ORAL 12,000 units-38,000 units-60,000 units; 24,000 units-76,000 units-120,000 units; 6000 units-19,000 units-30,000 units        


Therapeutic alternative:

Ordered Drug Therapeutic Alternate*

Zenpep Delayed-Release 5,000 units

Pancreaze Delayed-Release 4,200 units

Creon Delayed-Release 6,000 units

Zenpep Delayed-Release 10,000 units

Zenpep Delayed-Release 15,000 units

Pancreaze Delayed-Release 10,500 units

Pancreaze Delayed-Release 16,000 units

Creon Delayed-Release 12,000 units

Zenpep Delayed-Release 20,000 units

Pancreaze Delayed-Release 21,000 units

Creon Delayed-Release 24,000 units

*Pancreatic enzyme dose based on lipase content of capsules


Last updated: Jan. 2, 2026







This site is intended for the staff of Henry Ford Health.
While others may view accessible pages, Henry Ford Health makes no warranty, express or implied,
as to the use of this information outside of Henry Ford Health.